EMI-TB

EMI-TB

Posted on

Tuberculosis (TB) is a global health problem,
killing 1.5 million of people every year.
The primary outcome of EMI-TB will be a novel vaccine candidate for TB.
Continue Reading

Nanoimmunotech

Nanoimmunotech

Posted on

Nanoimmunotech is born from the cooperation of the Immunology Group from the Biomedical Research Center (CINBIO) of Vigo and the Nanoscience Institute of Aragón (INA). Continue Reading

Immunology Group

Over the years, this research group led by Prof. África González Fernández has developed several projects funded by Europe, the Spanish and Galician governments, foundations and also by private enterprises. Continue Reading